Impact Of Conditioning Regimen, Donor Source, and DIPSS Score On Outcome Of Allogeneic Hematopoietic Stem Cell Transplantation For Myelofibrosis

被引：1
|
作者：
Kroeger, Nicolaus
Ditschkowski, Markus
Scott, Bart L.
Zabelina, Tatjana
Alchalby, Haefaa
Beelen, Dietrich
Deeg, H. Joachim
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.712.712
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
712
引用
收藏
页数：2
相关论文
共 50 条
  • [41] RISK SCORE FOR OUTCOME AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDHOOD
    Arndt, C.
    Wolff, I.
    Beck, J. F.
    Gruhn, B.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S275 - S276
  • [42] Donor stem cell source does not impact outcome of high-risk acute myeloblastic leukaemia patients after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation
    Fuerst, S.
    Castagna, L.
    Prebet, T.
    El Cheikh, J.
    Faucher, C.
    Vey, N.
    Charbonnier, A.
    Ladaique, P.
    Chabannon, C.
    Blaise, D.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S160 - S160
  • [43] The Effect of Donor Age on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation
    Remberger, Mats
    Ali, Maryan
    Grenvold, Bjorn Christer
    Tjonnfjord, Geir Erland
    Mattsson, Jonas
    Lundin, Katrin Ulrike
    Myhre, Anders Eivind
    Abrahamsen, Ingerid Weum
    Gedde-dahl, Tobias
    Floisand, Yngvar
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S282 - S282
  • [44] Outcome of Alternative Donor Allogeneic Hematopoietic Stem Cell Transplantation in Erythpoietic Porphyria
    Saad, A.
    Moczynski, A.
    Sedlacek, P.
    Albert, M. H.
    Diaz de Heredia, C.
    Smiers, F. J.
    Bloomer, J.
    Gennery, A. R.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S295 - S295
  • [45] The Use of Allogeneic Hematopoietic Stem Cell Transplantation in Primary Myelofibrosis
    Wolfe, Heather R.
    Horwitz, Mitchell E.
    Rein, Lindsay A. M.
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (04):
  • [46] Allogeneic hematopoietic stem cell transplantation for infants with idiopathic myelofibrosis
    Hussein, Ayad Ahmed
    Hamadah, Tuka
    Domm, Jennifer
    Al-Zaben, Abdulhadi
    Frangoul, Haydar
    PEDIATRIC TRANSPLANTATION, 2013, 17 (08) : 815 - 819
  • [47] Impact of cytogenetics on prognosis in primary myelofibrosis after allogeneic hematopoietic stem cell transplantation
    Gagelmann, Nico
    Ditschkowski, Markus
    Bogda-Nov, Rashit
    Bredin, Swan
    Robin, Marie
    Cassinat, Bruno
    Shahswar, Rabia
    Thol, Felicitas
    Heuser, Michael
    Beelen, Dietrich
    Badbaran, Anita
    Kroeger, Nicolaus
    BONE MARROW TRANSPLANTATION, 2019, 54 : 49 - 51
  • [48] IMPACT OF MYELOFIBROSIS ON PATIENTS WITH MYELODYSPLASTIC SYNDROMES FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Zhu, Panpan
    Lai, Xiaoyu
    Liu, Lizhen
    Shi, Jimin
    Yu, Jian
    Zhao, Yanmin
    Yang, Luxin
    Zheng, Weiyan
    Sun, Jie
    Wu, Wenjun
    Huang, He
    Luo, Yi
    BONE MARROW TRANSPLANTATION, 2024, 59 : 246 - 247
  • [49] Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantation
    Zhu, Panpan
    Lai, Xiaoyu
    Liu, Lizhen
    Shi, Jimin
    Yu, Jian
    Zhao, Yanmin
    Yang, Luxin
    Yang, Tingting
    Zheng, Weiyan
    Sun, Jie
    Wu, Wenjun
    Zhao, Yi
    Cai, Zhen
    Huang, He
    Luo, Yi
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [50] Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantation
    Panpan Zhu
    Xiaoyu Lai
    Lizhen Liu
    Jimin Shi
    Jian Yu
    Yanmin Zhao
    Luxin Yang
    Tingting Yang
    Weiyan Zheng
    Jie Sun
    Wenjun Wu
    Yi Zhao
    Zhen Cai
    He Huang
    Yi Luo
    Journal of Translational Medicine, 22
12345